Unpa

Why the FDA reorg is the biggest story of the year

21-Dec-2023 By Danielle Masterson

UNPA’s Israelsen breaks down the FDA’s restructuring and issues a call to action for the future of the industry.

UNPA's reflections on 2023: The year of opposite choices

21-Dec-2023 By Loren Israelsen, Founder & President, United Natural Products Alliance (UNPA)

My reflection on 2023 has little to do with specifics. In my view, this was a year of opposite choices and opposing directions – the big stuff. Yet, daily demands to address the urgent (but often not so important) dulled our senses and intuition. Hence,...

UNPA’s Israelsen on AB 2098, FDA reorg and more

06-Nov-2023 By Danielle Masterson

We’ve seen a number of state bills prop up, especially out of California. In fact, at this time last year we were talking about AB 2098, a contentious bill that would have disciplined physicians for spreading misinformation about COVID. That bill was...

CA repeals "atrocious" law intended to curb COVID disinformation

19-Sep-2023 By Danielle Masterson

The United Natural Products Alliance is applauding the move, saying the repeal is a very significant and positive development, particularly for functional and alternative medicine physicians in the state.

UNPA’s Israelsen: ‘Dietary supplements are not food additives - full stop’

10-Jul-2023 By Stephen Daniells

FDA’s recent proposal to relocate the Office of Dietary Supplement Programs (ODSP) to a new Office of Food Chemical Safety, Dietary Supplements, and Innovation, is disturbing, says UNPA’s Loren Israelsen.

FDA proposes relocation of Office of Dietary Supplement Programs, industry reacts

06-Jul-2023 By Asia Sherman

The dietary supplement industry is expressing concern over a proposed update to a Food and Drug Administration (FDA) reorganization that would relocate the current Office of Dietary Supplement Programs (ODSP) to a new office under its “Risk Management...

FDA commissioners calls for supplements listing, wider regulatory changes

01-Mar-2023 By Stephen Daniells

Robert Califf, MD, Commissioner of Food and Drugs, has stated his hope for an “an improved framework to appropriately regulate dietary supplements”, including product listing.

UNPA and Radicle Science launch clinical trial partnership

10-Jan-2023 By Danielle Masterson

The collaboration aims to level the playing field between supplements and pharmaceuticals by giving UNPA members access to groundbreaking clinical trials on supplements.

Foreign policy and the US political landscape: Where does the natural products industry fit in?

21-Nov-2022 By Danielle Masterson

Dietary supplement use among Americans is an all-time high, with the US being the leading worldwide importer of vitamin products last year. With an estimated 90% of ingredients coming from China, US policymakers are zeroed in on foreign policy.

NutraWomen Wednesday: Larisa Pavlick, VP, Global Regulatory & Compliance, UNPA

27-Apr-2022 By Danielle Masterson

Larisa Pavlick has devoted her entire career to the supplement industry. She spent nearly a decade at FDA focused on consumer safety and also experienced the full product life cycle from the development phase, through purchasing, into manufacturing, brand...

UNPA offers support for China’s new customs regulations

31-Jan-2022 By Stephen Daniells

The United Natural Products Alliance (UNPA) is offering to help companies navigate China’s new customs decree, which went into effect on January 1.

UNPA's Israelsen on DSHEA 2.0 & CBD: ‘Unless there is unity, it just gets harder’

29-Apr-2021 By Stephen Daniells

Proposed modernizations to the Dietary Supplement Health and Education Act (DSHEA) and solutions to the CBD issue require “an outstanding effort by industry to speak with a united voice”, says Loren Israelsen, President of the United Natural Products...

Hemp-CBD dietary supplement bill introduced in the House

04-Sep-2020 By Stephen Daniells

Rep. Kurt Schrader (D-OR) and Rep. Morgan Griffith (R-VA) have introduced the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 to allow hemp and hemp derived CBD to be legally marketed in dietary supplements.

Is FTC pushing back on structure/function claims territory, asks UNPA’s Israelsen

27-Jul-2020 By Stephen Daniells

Many recent warning letters from the Federal Trade Commission about COVID-19 are warranted, says UNPA’s Loren Israelsen, but some targeting health practitioners and what our industry has to offer in the broader immunity discussion may hint at redefining...

FTC refunds $8.5 million to consumers over fraudulent product claims

20-May-2020 By Danielle Masterson

The Federal Trade Commission just announced it is issuing refund checks totaling over $8.5 million to consumers defrauded by misleading claims on weight loss products an erectile dysfunction product in a case dating back to 2004.

UNPA’s Israelsen: ‘We’ve had a good six weeks, but consumers have used some of their last spending power to buy supplements’

04-May-2020 By Stephen Daniells

While dietary supplement sales have surged in recent months, the extent of the economic damage caused by the novel coronavirus and COVID-19 could lead to some very tough quarters as families and businesses start to run out of money.